sukarti, sukarti and Infianto, Andreas and mustofa, syazili (2023) SURVIVAL RATE ANALYSIS OF LUNG ADENOCARCINOMA PATIENTS RECEIVING EGFR-TKI TREATMENT WITH CARBOPLATIN AND PACLITACLE CHEMOTHERAPY IN THE COVID-19 PANDEMIC AT Dr.Hi. ABDUL MOELOEK REGIONAL PUBLIC HOSPITAL, BANDAR LAMPUNG. In: 24th International Meeting on Respiratory Care Indonesia, 2023/06/18, Jakarta.

[img]
Preview
Text
Respina-2023_eProceeding-Book_Website.pdf

Download (12MB) | Preview
Official URL: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&so...

Abstract

Background: The benchmark for the success of cancer treatment is the survival rate. Although the hope for survival is increasing, there are still concerns regarding the cost of treating lung cancer with targeted therapy which is very expensive and has not yet been included in the national formulary for third generation EGFR-TKI target therapy (osimertinib). Method : Analytic descriptive with retrospective cohort design processed with SPSS 25 with log rank test and shown with Kaplan Meier product limit curve. Data was taken at Dr.Hi.Abdul Moeloek Hospital from January 2020 to December 2022 during the Covid 19 pandemic. Results : Group of Lung adenocarcinoma treated by EGFR-TKI 39 subjects. The lung adenocarcinoma group was treated with paclitaxel-carboplatin 53 subjects.The median survival time of the group treated with EGFR-TKI was 7 (95% CI: 3.805-10.195) months, while the group receiving paclitaxel carboplatin was 5 months (95% CI: 3.788- while the overall median survival was 6 months (95% CI: 4.836- 7.164) there is no significant difference with the p value: 0.209. Conclusion: The median survival rate of two groups at 6 months was not significantly different Keyword: Adenocarsinoma, survival rate, EGFR-TKI, carboplatin-paclitacle, covid 1

Item Type: Conference or Workshop Item (Paper)
Subjects: R Medicine > R Medicine (General)
Divisions: Fakultas Kedokteran (FK) > Prodi Pendidikan Dokter
Depositing User: Dr.Si. dr. Syazili Mustofa
Date Deposited: 25 Jul 2023 08:04
Last Modified: 25 Jul 2023 08:04
URI: http://repository.lppm.unila.ac.id/id/eprint/52303

Actions (login required)

View Item View Item